BVB RON

Zentiva S.A. (SCD.RO)

Compare
4.5200
0.0000
(0.00%)
As of November 20 at 5:07:35 PM GMT+2. Market Open.
Loading Chart for SCD.RO
DELL
  • Previous Close 4.5200
  • Open 4.4200
  • Bid --
  • Ask 5.0000 x --
  • Day's Range 4.4200 - 4.5200
  • 52 Week Range 2.7800 - 4.6000
  • Volume 2,573
  • Avg. Volume 1,121
  • Market Cap (intraday) 3.151B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 11.59
  • EPS (TTM) 0.3900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 16, 2017
  • 1y Target Est --

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients. The company was formerly known as Sicomed S.A. and changed its name to Zentiva S.A. in January 2006. The company was founded in 1962 and is based in Bucharest, Romania. Zentiva S.A. is a subsidiary of Zentiva Group a.s.

www.zentiva.ro

1,035

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SCD.RO

View More

Performance Overview: SCD.RO

Trailing total returns as of 1/22/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

SCD.RO
0.00%
MSCI WORLD
2.82%

1-Year Return

SCD.RO
54.79%
MSCI WORLD
0.00%

3-Year Return

SCD.RO
86.78%
MSCI WORLD
26.40%

5-Year Return

SCD.RO
38.65%
MSCI WORLD
58.71%

Compare To: SCD.RO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SCD.RO

View More

Valuation Measures

Annual
As of 1/21/2025
  • Market Cap

    3.15B

  • Enterprise Value

    3.15B

  • Trailing P/E

    11.59

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.88

  • Price/Book (mrq)

    2.26

  • Enterprise Value/Revenue

    2.88

  • Enterprise Value/EBITDA

    9.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.97%

  • Return on Assets (ttm)

    11.02%

  • Return on Equity (ttm)

    21.89%

  • Revenue (ttm)

    1.05B

  • Net Income Avi to Common (ttm)

    263.29M

  • Diluted EPS (ttm)

    0.3900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.88M

  • Total Debt/Equity (mrq)

    1.55%

  • Levered Free Cash Flow (ttm)

    -81.06M

Research Analysis: SCD.RO

View More

Company Insights: SCD.RO

Research Reports: SCD.RO

View More